Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 466.00M | £ 280.00M | £ 807.00M | £ 581.00M | £ 805.00M |
Total Assets | £ 6.86B | £ 6.67B | £ 7.51B | £ 7.74B | £ 8.35B |
Total Debt | £ 1.39B | £ 1.25B | £ 1.46B | £ 1.37B | £ 1.69B |
Net Debt | £ 928.00M | £ 969.00M | £ 657.00M | £ 792.00M | £ 887.00M |
Total Liabilities | £ 4.32B | £ 4.22B | £ 4.84B | £ 5.06B | £ 5.65B |
Stockholders Equity | £ 2.54B | £ 2.44B | £ 2.67B | £ 2.69B | £ 2.70B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |